10/17/2025
not to mention the huge decrease in fertility connected with this vaccine. Do what you want with your body but please look at the risks associated.
🚨 The HPV Vaccine: Merck’s Deceptive Playbook Repeated with COVID-19
Merck’s Gardasil, rushed to market in 2006 after the Vioxx scandal, was sold as a cervical cancer savior, but the data reveals a chilling tale of harm and cover-up, eerily mirrored in the COVID-19 vaccine rollout.
Clinical trials showed 49.6% of Gardasil participants developed “New Medical Conditions,” with 2.3% exhibiting autoimmune disorders like Guillain-Barré syndrome, multiple sclerosis, POTS, lupus, and primary ovarian failure.
A 2020 Cochrane review of 24 studies involving 100,000 people found moderate to high bias, with 72% of trials failing to track harms and flagging signals for POTS and complex regional pain syndrome.
By 2007, the CDC’s VAERS logged 8,864 adverse events, including 38 Guillain-Barré cases and 18 deaths—like a 17-year-old who died of myocarditis two days after her third dose.
Trials reported 10 deaths among 21,458 recipients (8.5 per 10,000, nearly double the background rate), often tied to car crashes linked to POTS-induced dizziness.
Fertility data is stark: Gardasil 9 trials showed a 27.4% miscarriage rate (17 of 62 pregnancies), spiking near conception, while U.S. teen birth rates for girls under 18 dropped 44% post-rollout.
Most shockingly, Merck’s data and a 2017 Annals of Medicine study suggest that for the 85% of people already exposed to HPV, the vaccine could increase cervical cancer risk by up to 1.29 times by provoking latent infections.
VAERS noted 78 cases of new or worsening HPV outbreaks, including severe warts in unexposed girls days after vaccination.
This mirrors Merck’s Vioxx scandal, where concealed heart attack risks caused 88,000–140,000 excess cases and up to 55,000 deaths, costing $4.85 billion in settlements.
With Gardasil, Merck used the same playbook: trials employed toxic aluminum-containing “placebos” (AAHS) to mask harms, reporting a 2.3% autoimmune rate in both groups to falsely claim safety.
Despite 78% of trial participants using hormonal contraceptives—a clotting risk with Gardasil—no warnings were issued.
The FDA, aware of 8,864 VAERS reports and 18 deaths by 2007 via Judicial Watch FOIAs, dismissed them as “unrelated,” ignoring 3,779 complaints, including 5 sudden deaths and hundreds of cardiac and neurological cases.
By 2013, $5.9 million was paid to 47 injured girls and 2 families of deceased victims, with 92 claims pending, yet no follow-up occurred.
Merck hid a 2007 presentation showing a 44.6% increased rate of high-grade cervical lesions in HPV-positive vaccinated girls, omitting this from public reports.
The CDC fast-tracked Gardasil onto the childhood vaccine schedule within a year, fueled Merck’s fear-driven “One Less” campaign, and brushed off the tripled VAERS rate as “media hype.”
Globally, India reported 7 deaths in Merck- and Gates-funded trials marred by consent violations; Japan suspended the vaccine in 2013 after severe side effects sparked outrage.
Long-term data shows no clear drop in cervical cancer mortality, with rates already declining due to Pap smears since the 1940s.
The HPV vaccine rollout was a blueprint for the COVID-19 vaccine push.
Both were rushed—Gardasil post-Vioxx, COVID via Emergency Use Authorizations—skipping long-term safety data.
Merck and pharma giants used fear-based marketing, overstated efficacy, and buried adverse events.
Regulators ignored VAERS spikes (Gardasil’s neurological harms, COVID’s myocarditis and clotting risks), used flawed trial designs, and dismissed injuries as “unrelated.”
Gardasil’s “One Less” campaign mirrored COVID’s “Do Your Part” messaging, enforcing compliance while silencing dissent.
Young girls bore Gardasil’s brunt; young men faced COVID vaccine risks.
FOIAs exposed hidden trial flaws and injury payouts, revealing regulatory collusion and profit-driven cover-ups that set the stage for COVID’s global rollout.
This undeniable evidence demands accountability.
The HPV and COVID vaccine sagas expose how Merck, the FDA, and the CDC prioritize profits over lives.